A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruiting · NCT05924750 · Registry updated 2025-09-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2025-09-26 | NCT05924750 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd. | 135 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | China | 28 |
| Beijing Hospital | Beijing | China | 15 |
| Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences | Tianjin | China | 8 |
| Institute of Hematology, the First Hospital of Harbin | Haerbin | China | 1 |
| Qilu Hospital of Shandong University | Jinan | China | 5 |
| Shanghai Tongji Hospital | Shanghai | China | 7 |
| Shengjing Hospital of China Medical University | Shenyang | China | 32 |
| West China Hospital，Sichuan University | Chengdu | China | 12 |